NIH-funded research R21 grant

Identifying Parkinson's disease biomarkers in nasal mucus

Official title: Parkinson’s disease biomarkers in human olfactory cleft mucus

Funded at Monell Chemical Senses Center · NIH-10659011 · Data updated 2026-11-12

This study is looking at how the mucus from your nose might help find early signs of Parkinson's disease, especially since changes in smell can happen before other symptoms show up, and it hopes to discover helpful markers for earlier diagnosis and treatment.

More s Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMonell Chemical Senses Center
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 4, 2022
Project endJune 30, 2025
Funding year2023
Award (this year)$168,974
NIH project number5R21DC020033-02
Project IDNIH-10659011 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing early symptoms of Parkinson's disease, particularly those with olfactory impairments.

Less likely to help

Patients who have already been diagnosed with advanced Parkinson's disease and exhibit significant motor deficits may not benefit from this research.

What this research studies

This research investigates the potential of using human olfactory cleft mucus to identify biomarkers for Parkinson's disease (PD). It focuses on the early symptoms of PD, particularly olfactory impairment, which can occur years before motor symptoms appear. By analyzing proteins in the mucus, the study aims to find reliable indicators of PD that could lead to earlier diagnosis and intervention. The approach includes proteomics studies to examine the presence of specific proteins associated with PD.

Why it matters

Potential benefit: If successful, this research could enable earlier diagnosis of Parkinson's disease, allowing for timely treatment and management.

How similar studies have gone: Other research has shown promise in identifying biomarkers for neurodegenerative diseases through similar approaches, indicating potential for success in this area.

Where this research is happening

  • Monell Chemical Senses Center
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Wang, Hong — Monell Chemical Senses Center
  • Study coordinator: Wang, Hong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.